EAMA
CRL icon

EFG Asset Management (Americas)’s Charles River Laboratories CRL Stock Holding History

EFG Asset Management (Americas)’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-750
Closed -$203K – 126
2024
Q1 		$203K Sell
750
-279
-27% -$66.6K 0.06% 124
2023
Q4 		$243K Sell
1,029
-136
-12% -$26.7K 0.05% 135
2023
Q3 		$228K Buy
1,165
+73
+7% +$15K 0.05% 134
2023
Q2 		$230K Buy
+1,092
New +$217K 0.05% 137

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.6B AUM 15.71% 1-Year Est. Return
SCA
Southpoint Capital Advisors New York $4.4B AUM 49.36% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

EFG Asset Management (Americas)'s CRL Position: Q2 2024 in Review

EFG Asset Management (Americas) sold out of Charles River Laboratories (CRL) in Q2 2024, closing a stake of 750 shares — an estimated $203K sold.

EFG Asset Management (Americas) first reported a position in CRL in Q2 2023 and held it in 4 quarters. The position peaked at $243K in Q4 2023. 665 funds tracked by Wall St. Rank hold CRL as of Q2 2024.

  • EFG Asset Management (Americas) reported no remaining Charles River Laboratories position as of Q2 2024 after selling out during the quarter.
  • EFG Asset Management (Americas) sold 750 Charles River Laboratories shares in Q2 2024, an estimated $203K.
  • EFG Asset Management (Americas) first reported a position in Charles River Laboratories in Q2 2023 and held it in 4 quarters.
  • EFG Asset Management (Americas)'s Charles River Laboratories position peaked at $243K in Q4 2023.
  • 665 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2024.

Based on EFG Asset Management (Americas)'s 13F filing for Q2 2024, filed 6 Aug 2024.